Sep 28, 20221 min readA Treatment for Patients with METex14 Skipping Metastatic NSCLC ~ 10/4/22 @ 6pmINTERESTED!? Please contact Sarah Sievering directly via text or call to 617-549-4146. Feel free to email her as well.ONS Boston Meeting 10.4.pdfDownload PDF • 1.20MB
INTERESTED!? Please contact Sarah Sievering directly via text or call to 617-549-4146. Feel free to email her as well.ONS Boston Meeting 10.4.pdfDownload PDF • 1.20MB
The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3
Hello All! If interested in attending please contact Sarah directly at her email sarah.sievering@emdserono.com or by phone at 617-549-4146. Thank you!